Considering the overexpression of HMGCR in cancer tissue and regenerating muscle cells [40, 41], together with the finding that the target of this antibody plays a role in oncogenesis [42–44], an association with cancer may have contributed to the development of anti-HMGCR-positive myopathy. Here, HMGCR is linked to cancer.